| Year |
Citation |
Score |
| 2023 |
Cagol A, Cortese R, Barakovic M, Schaedelin S, Ruberte E, Absinta M, Barkhof F, Calabrese M, Castellaro M, Ciccarelli O, Cocozza S, De Stefano N, Enzinger C, Filippi M, Jurynczyk M, et al. Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis. Jama Neurology. PMID 38079177 DOI: 10.1001/jamaneurol.2023.4737 |
0.476 |
|
| 2023 |
Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, et al. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY). Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 37610702 DOI: 10.1007/s13311-023-01415-y |
0.363 |
|
| 2023 |
Magliozzi R, Howell OW, Calabrese M, Reynolds R. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nature Reviews. Neurology. PMID 37400550 DOI: 10.1038/s41582-023-00838-7 |
0.411 |
|
| 2023 |
Gajofatto A, Cardobi N, Gobbin F, Calabrese M, Turatti M, Benedetti MD. Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity. Bmc Neurology. 23: 128. PMID 36991352 DOI: 10.1186/s12883-023-03171-0 |
0.454 |
|
| 2023 |
Pezzini F, Pisani A, Mazziotti V, Marastoni D, Tamanti A, Borroni E, Magon S, Zinnhardt B, Magliozzi R, Calabrese M. Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF. International Journal of Molecular Sciences. 24. PMID 36835179 DOI: 10.3390/ijms24043768 |
0.346 |
|
| 2023 |
Ziccardi S, Pisani AI, Schiavi GM, Guandalini M, Crescenzo F, Colombi A, Peloso A, Tamanti A, Bertolazzo M, Marastoni D, Calabrese M. Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. European Journal of Neurology. PMID 36692863 DOI: 10.1111/ene.15697 |
0.402 |
|
| 2022 |
Ziccardi S, Pizzini FB, Guandalini M, Tamanti A, Cristofori C, Calabrese M. Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis. Bioengineering (Basel, Switzerland). 10. PMID 36671613 DOI: 10.3390/bioengineering10010041 |
0.366 |
|
| 2022 |
Ponzano M, Schiavetti I, Bergamaschi R, Pisoni E, Bellavia A, Mallucci G, Carmisciano L, Inglese M, Cordioli C, Marfia GA, Cocco E, Immovilli P, Pesci I, Scandellari C, Cavalla P, ... ... Calabrese M, et al. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study. Multiple Sclerosis and Related Disorders. 68: 104243. PMID 36288659 DOI: 10.1016/j.msard.2022.104243 |
0.324 |
|
| 2022 |
Andretta E, Finazzi Agrò E, Calabrese M, Orecchia L, Furlan A, Zuliani C. Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data. Therapeutic Advances in Urology. 14: 17562872221122484. PMID 36172491 DOI: 10.1177/17562872221122484 |
0.396 |
|
| 2022 |
Meaton I, Altokhis A, Allen CM, Clarke MA, Sinnecker T, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, et al. Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221118677. PMID 36017870 DOI: 10.1177/13524585221118677 |
0.373 |
|
| 2022 |
Baroncini D, Ghezzi A, Guaschino C, Moiola L, Filippi M, Ianniello A, Pozzilli C, Lanzillo R, Brescia-Morra V, Margoni M, Gallo P, Callari G, Grimaldi L, Lus G, Calabrese M, et al. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 35781765 DOI: 10.1007/s10072-022-06211-8 |
0.427 |
|
| 2022 |
Marastoni D, Crescenzo F, Pisani AI, Zuco C, Schiavi G, Benedetti G, Ricciardi GK, Montemezzi S, Pizzini FB, Tamanti A, Calabrese M. Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221104014. PMID 35765211 DOI: 10.1177/13524585221104014 |
0.413 |
|
| 2022 |
Marastoni D, Pisani AI, Schiavi G, Mazziotti V, Castellaro M, Tamanti A, Bosello F, Crescenzo F, Ricciardi GK, Montemezzi S, Pizzini FB, Calabrese M. CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis. Therapeutic Advances in Neurological Disorders. 15: 17562864221092124. PMID 35755969 DOI: 10.1177/17562864221092124 |
0.347 |
|
| 2022 |
Magliozzi R, Fadda G, Brown RA, Bar-Or A, Howell OW, Hametner S, Marastoni D, Poli A, Nicholas R, Calabrese M, Monaco S, Reynolds R. "Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis. Annals of Neurology. PMID 35748636 DOI: 10.1002/ana.26448 |
0.396 |
|
| 2022 |
Pitteri M, Dapor C, DeLuca J, Chiaravalloti ND, Marastoni D, Calabrese M. Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients. Journal of the International Neuropsychological Society : Jins. 1-7. PMID 35465860 DOI: 10.1017/S1355617722000157 |
0.373 |
|
| 2021 |
Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F, Montemezzi S, Pizzini FB, Calabrese M. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34588298 DOI: 10.1212/NXI.0000000000001083 |
0.468 |
|
| 2021 |
Bajrami A, Magliozzi R, Pisani AI, Pizzini FB, Crescenzo F, Marastoni D, Calabrese M. Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 28: 550-560. PMID 34378437 DOI: 10.1177/13524585211031786 |
0.436 |
|
| 2021 |
Magliozzi R, Pezzini F, Pucci M, Rossi S, Facchiano F, Marastoni D, Montagnana M, Lippi G, Reynolds R, Calabrese M. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation. Cells. 10. PMID 34359880 DOI: 10.3390/cells10071712 |
0.305 |
|
| 2021 |
Pitteri M, Magliozzi R, Nicholas R, Ziccardi S, Pisani AI, Pezzini F, Marastoni D, Calabrese M. Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211032510. PMID 34328817 DOI: 10.1177/13524585211032510 |
0.465 |
|
| 2021 |
Boscolo Galazzo I, Brusini L, Akinci M, Cruciani F, Pitteri M, Ziccardi S, Bajrami A, Castellaro M, Salih AMA, Pizzini FB, Jovicich J, Calabrese M, Menegaz G. Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes. Journal of Magnetic Resonance Imaging : Jmri. PMID 34189804 DOI: 10.1002/jmri.27806 |
0.367 |
|
| 2021 |
Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211018987. PMID 34048323 DOI: 10.1177/13524585211018987 |
0.351 |
|
| 2021 |
Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, Evangelou N, Filippi M, Geurts JJG, Reich DS, Rocca MA, Ropele S, Rovira À, Sati P, Toosy AT, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain : a Journal of Neurology. PMID 33970206 DOI: 10.1093/brain/awab029 |
0.352 |
|
| 2021 |
Crescenzo F, Marastoni D, Pisani AI, Tamanti A, Dapor C, Colombi A, Brillo A, Magliozzi R, Pizzini FB, Castellaro M, Calabrese M. The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study. Diagnostics (Basel, Switzerland). 11. PMID 33921278 DOI: 10.3390/diagnostics11040686 |
0.476 |
|
| 2021 |
Pisani AI, Scalfari A, Crescenzo F, Romualdi C, Calabrese M. A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients. European Journal of Neurology. 28: 2503-2512. PMID 33835665 DOI: 10.1111/ene.14859 |
0.419 |
|
| 2021 |
Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. A Videogame-Based Approach to Measuring Information Processing Speed in Multiple Sclerosis Patients. Games For Health Journal. 10: 115-120. PMID 33818136 DOI: 10.1089/g4h.2020.0069 |
0.323 |
|
| 2021 |
Ziccardi S, Pitteri M, Genova HM, Calabrese M. Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study. Diagnostics (Basel, Switzerland). 11. PMID 33803307 DOI: 10.3390/diagnostics11030484 |
0.313 |
|
| 2021 |
Calabrese M, Marastoni D, Crescenzo F, Scalfari A. Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients. Current Opinion in Neurology. 34: 277-285. PMID 33661162 DOI: 10.1097/WCO.0000000000000921 |
0.374 |
|
| 2021 |
Magliozzi R, Pitteri M, Ziccardi S, Pisani AI, Montibeller L, Marastoni D, Rossi S, Mazziotti V, Guandalini M, Dapor C, Schiavi G, Tamanti A, Nicholas R, Reynolds R, Calabrese M. CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 33484486 DOI: 10.1002/acn3.51298 |
0.417 |
|
| 2020 |
Castellaro M, Tamanti A, Pisani AI, Pizzini FB, Crescenzo F, Calabrese M. The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis. Diagnostics (Basel, Switzerland). 10. PMID 33260401 DOI: 10.3390/diagnostics10121025 |
0.432 |
|
| 2020 |
Magliozzi R, Mazziotti V, Montibeller L, Pisani AI, Marastoni D, Tamanti A, Rossi S, Crescenzo F, Calabrese M. Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients. Frontiers in Cellular Neuroscience. 14: 569827. PMID 33192314 DOI: 10.3389/fncel.2020.569827 |
0.464 |
|
| 2020 |
Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opinion On Therapeutic Targets. 24: 1135-1145. PMID 32900236 DOI: 10.1080/14728222.2020.1821647 |
0.473 |
|
| 2020 |
Moccia M, Annovazzi P, Buscarinu MC, Calabrese M, Cavalla P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Gallo A, Lanzillo R, Laroni A, Lorefice L, Mallucchi S, Nociti V, et al. Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group. Multiple Sclerosis and Related Disorders. 45: 102394. PMID 32683308 DOI: 10.1016/J.Msard.2020.102394 |
0.497 |
|
| 2020 |
Crescenzo F, Marastoni D, Bovo C, Calabrese M. Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy. Multiple Sclerosis and Related Disorders. 44: 102372. PMID 32650121 DOI: 10.1016/J.Msard.2020.102372 |
0.458 |
|
| 2020 |
Magliozzi R, Scalfari A, Pisani AI, Ziccardi S, Marastoni D, Pizzini FB, Bajrami A, Tamanti A, Guandalini M, Bonomi S, Rossi S, Mazziotti V, Castellaro M, Montemezzi S, Rasia S, ... ... Calabrese M, et al. The CSF profile linked to cortical damage predicts Multiple Sclerosis activity. Annals of Neurology. PMID 32418239 DOI: 10.1002/Ana.25786 |
0.523 |
|
| 2020 |
Tortorella C, Solaro C, Annovazzi P, Boffa L, Buscarinu MC, Buttari F, Calabrese M, Cavalla P, Cocco E, Cordioli C, De Luca G, Di Filippo M, Fantozzi R, Ferraro D, Gajofatto A, et al. Informing MS patients on treatment options: a consensus on the process of consent taking. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 32240416 DOI: 10.1007/S10072-020-04339-Z |
0.493 |
|
| 2020 |
Pitteri M, Vannucci M, Ziccardi S, Beccherle M, Semenza C, Calabrese M. False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm. Multiple Sclerosis and Related Disorders. 37: 101418. PMID 32172993 DOI: 10.1016/J.Msard.2019.101418 |
0.367 |
|
| 2019 |
Pitteri M, Dapor C, Pisani AI, Castellaro M, DeLuca J, Chiaravalloti N, Guandalini M, Ziccardi S, Calabrese M. Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results. Journal of Neuropsychology. PMID 31785082 DOI: 10.1111/Jnp.12198 |
0.303 |
|
| 2019 |
Pitteri M, Ziccardi S, Dapor C, Guandalini M, Calabrese M. Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly Diagnosed RRMS Patients. Brain Sciences. 9. PMID 31766124 DOI: 10.3390/Brainsci9110321 |
0.392 |
|
| 2019 |
Ferraro D, Annovazzi P, Moccia M, Lanzillo R, De Luca G, Nociti V, Fantozzi R, Paolicelli D, Ragonese P, Gajofatto A, Boffa L, Cavalla P, Lo Fermo S, Buscarinu MC, Lorefice L, ... ... Calabrese M, et al. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study. Multiple Sclerosis and Related Disorders. 37: 101461. PMID 31678859 DOI: 10.1016/J.Msard.2019.101461 |
0.524 |
|
| 2019 |
Magliozzi R, Hametner S, Facchiano F, Marastoni D, Rossi S, Castellaro M, Poli A, Lattanzi F, Visconti A, Nicholas R, Reynolds R, Monaco S, Lassmann H, Calabrese M. Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 31675181 DOI: 10.1002/Acn3.50893 |
0.506 |
|
| 2019 |
Magliozzi R, Marastoni D, Rossi S, Castellaro M, Mazziotti V, Pitteri M, Gajofatto A, Monaco S, Benedetti MD, Calabrese M. Increase of CSF inflammatory profile in a case of highly active multiple sclerosis Bmc Neurology. 19: 1-5. PMID 31558148 DOI: 10.1186/S12883-019-1455-7 |
0.421 |
|
| 2019 |
Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, et al. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis. Jama Neurology. PMID 31424490 DOI: 10.1001/Jamaneurol.2019.2478 |
0.481 |
|
| 2019 |
Marastoni D, Buriani A, Pisani AI, Crescenzo F, Zuco C, Fortinguerra S, Sorrenti V, Marenda B, Romualdi C, Magliozzi R, Monaco S, Calabrese M. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study. Frontiers in Immunology. 10: 1666. PMID 31379857 DOI: 10.3389/Fimmu.2019.01666 |
0.33 |
|
| 2019 |
Gajofatto A, Donisi V, Busch IM, Gobbin F, Butturini E, Calabrese M, Carcereri de Prati A, Cesari P, Del Piccolo L, Donadelli M, Fabene P, Fochi S, Gomez-Lira M, Magliozzi R, Malerba G, et al. Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis. Bmj Open. 9: e030469. PMID 31377712 DOI: 10.1136/Bmjopen-2019-030469 |
0.501 |
|
| 2019 |
Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, Fantozzi R, Prosperini L, Annovazzi P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Malucchi S, Lo Fermo S, et al. "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study. Neurology. PMID 31043476 DOI: 10.1212/Wnl.0000000000007573 |
0.551 |
|
| 2019 |
Pitteri M, Genova H, Lengenfelder J, DeLuca J, Ziccardi S, Rossi V, Calabrese M. Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment. Multiple Sclerosis and Related Disorders. 29: 118-123. PMID 30710839 DOI: 10.1016/J.Msard.2019.01.030 |
0.409 |
|
| 2019 |
Marastoni D, Lai-Cheong J, Magliozzi R, Calabrese M, Nicholas R. 174 Sclerosing dermopathy after alemtuzumab for multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.154 |
0.38 |
|
| 2018 |
Crescenzo F, Marastoni D, Zuco C, Pitteri M, Magliozzi R, Monaco S, Calabrese M. Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 27: 305-311. PMID 30453199 DOI: 10.1016/J.Msard.2018.11.009 |
0.563 |
|
| 2018 |
Magliozzi R, Reynolds R, Calabrese M. MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course. Brain Pathology (Zurich, Switzerland). PMID 30020563 DOI: 10.1111/Bpa.12642 |
0.581 |
|
| 2018 |
Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H, et al. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage. Clinical. 19: 466-475. PMID 29984155 DOI: 10.1016/J.Nicl.2018.04.023 |
0.532 |
|
| 2018 |
Bajrami A, Pitteri M, Castellaro M, Pizzini F, Romualdi C, Montemezzi S, Monaco S, Calabrese M. The effect of fingolimod on focal and diffuse grey matter damage in active MS patients. Journal of Neurology. PMID 29938336 DOI: 10.1007/S00415-018-8952-2 |
0.511 |
|
| 2018 |
Calabrese M. Multiple sclerosis and epilepsy: much more than a coincidence. European Journal of Neurology. 25: 1103-1104. PMID 29931718 DOI: 10.1111/Ene.13727 |
0.431 |
|
| 2018 |
Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis. Neurology. PMID 29769373 DOI: 10.1212/Wnl.0000000000005685 |
0.519 |
|
| 2018 |
Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, ... ... Calabrese M, et al. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. Journal of Neurology. PMID 29549468 DOI: 10.1007/S00415-018-8831-X |
0.368 |
|
| 2018 |
Magliozzi R, Howell OW, Nicholas R, Cruciani C, Castellaro M, Romualdi C, Rossi S, Pitteri M, Benedetti MD, Gajofatto A, Pizzini FB, Montemezzi S, Rasia S, Capra R, Bertoldo A, ... ... Calabrese M, et al. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Annals of Neurology. PMID 29518260 DOI: 10.1002/Ana.25197 |
0.54 |
|
| 2018 |
Pitteri M, Magliozzi R, Bajrami A, Camera V, Calabrese M. Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables. Expert Opinion On Pharmacotherapy. 1-9. PMID 29397790 DOI: 10.1080/14656566.2018.1434143 |
0.556 |
|
| 2017 |
Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D, Farinazzo A, Capra R, Mancinelli C, De Rossi N, Bombardi R, Zuliani L, Zoccarato M, Tanel R, Bonora A, ... ... Calabrese M, et al. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. Journal of Neurology. PMID 29063242 DOI: 10.1007/S00415-017-8635-4 |
0.328 |
|
| 2017 |
Gobbin F, Marangi A, Orlandi R, Richelli S, Turatti M, Calabrese M, Forgione A, Alessandrini F, Benedetti MD, Monaco S, Gajofatto A. A case of acute fulminant multiple sclerosis treated with alemtuzumab. Multiple Sclerosis and Related Disorders. 17: 9-11. PMID 29055482 DOI: 10.1016/J.Msard.2017.06.007 |
0.478 |
|
| 2017 |
Calabrese M, Pitteri M, Farina G, Bajrami A, Castellaro M, Magliozzi R, Monaco S. Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28844068 DOI: 10.1136/Jnnp-2017-316236 |
0.42 |
|
| 2017 |
Preziosa P, Rocca MA, Mesaros S, Meani A, Montalban X, Drulovic J, Droby A, Zipp F, Calabrese M, Sastre-Garriga J, Dujmovic-Basuroski I, Rovira A, Filippi M. Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28724720 DOI: 10.1136/Jnnp-2017-315863 |
0.482 |
|
| 2017 |
Castellaro M, Magliozzi R, Palombit A, Pitteri M, Silvestri E, Camera V, Montemezzi S, Pizzini FB, Bertoldo A, Reynolds R, Monaco S, Calabrese M. Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 28408633 DOI: 10.3174/Ajnr.A5150 |
0.474 |
|
| 2017 |
Calabrese M, Castellaro M. Cortical Gray Matter MR Imaging in Multiple Sclerosis. Neuroimaging Clinics of North America. 27: 301-312. PMID 28391788 DOI: 10.1016/J.Nic.2016.12.009 |
0.412 |
|
| 2017 |
Ferraro D, Franciotta D, Bedin R, Solaro C, Cocco E, Santangelo M, Immovilli P, Gajofatto A, Calabrese M, Di Filippo M, Orlandi R, Simone AM, Vitetta F, Capello E, Giunti D, et al. A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band. Journal of Neurology. PMID 28382419 DOI: 10.1007/S00415-017-8480-5 |
0.428 |
|
| 2017 |
Zimatore DS, Trentadue M, Castellaro M, Ferlisi M, Piovan E, Calabrese M. A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia. The Neuroradiology Journal. 1971400917697732. PMID 28379049 DOI: 10.1177/1971400917697732 |
0.533 |
|
| 2017 |
Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A, Benedetti MD, Facchiano F, Monaco S, Calabrese M. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. Journal of Neuroinflammation. 14: 40. PMID 28222766 DOI: 10.1186/S12974-017-0812-Y |
0.495 |
|
| 2017 |
Turri G, Calabrese M, Pancheri E, Monaco S, Gajofatto A, Marafioti V. QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? European Journal of Neurology. PMID 28111831 DOI: 10.1111/Ene.13229 |
0.528 |
|
| 2016 |
Eshaghi A, Wottschel V, Cortese R, Calabrese M, Sahraian MA, Thompson AJ, Alexander DC, Ciccarelli O. Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest. Neurology. PMID 27807185 DOI: 10.1212/Wnl.0000000000003395 |
0.488 |
|
| 2016 |
Pitteri M, Romualdi C, Magliozzi R, Monaco S, Calabrese M. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27527906 DOI: 10.1177/1352458516665496 |
0.559 |
|
| 2016 |
Sormani MP, Gasperini C, Romeo M, Rio J, Calabrese M, Cocco E, Enzingher C, Fazekas F, Filippi M, Gallo A, Kappos L, Marrosu MG, Martinelli V, Prosperini L, Rocca MA, et al. Assessing response to interferon-β in a multicenter dataset of patients with MS. Neurology. 87: 134-40. PMID 27306626 DOI: 10.1212/Wnl.0000000000002830 |
0.51 |
|
| 2016 |
Calabrese M, Castellaro M, Bertoldo A, De Luca A, Pizzini FB, Ricciardi GK, Pitteri M, Zimatore S, Magliozzi R, Benedetti MD, Manganotti P, Montemezzi S, Reynolds R, Gajofatto A, Monaco S. Epilepsy in multiple sclerosis: The role of temporal lobe damage. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27260699 DOI: 10.1177/1352458516651502 |
0.444 |
|
| 2015 |
Calabrese M, Reynolds R, Magliozzi R, Castellaro M, Morra A, Scalfari A, Farina G, Romualdi C, Gajofatto A, Pitteri M, Benedetti MD, Monaco S. Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients. Plos One. 10: e0135428. PMID 26267665 DOI: 10.1371/Journal.Pone.0135428 |
0.538 |
|
| 2015 |
Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nature Reviews. Neuroscience. 16: 147-58. PMID 25697158 DOI: 10.1038/Nrn3900 |
0.357 |
|
| 2015 |
Calabrese M, Gajofatto A, Gobbin F, Turri G, Richelli S, Matinella A, Oliboni ES, Benedetti MD, Monaco S. Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 580-9. PMID 25432947 DOI: 10.1177/1352458514542363 |
0.448 |
|
| 2014 |
Calabrese M, Gajofatto A, Benedetti MD. Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. Expert Review of Neurotherapeutics. 14: 1417-28. PMID 25391525 DOI: 10.1586/14737175.2014.979794 |
0.472 |
|
| 2014 |
Calabrese M, De Stefano N. Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 537-8. PMID 24692503 DOI: 10.1177/1352458514526084 |
0.429 |
|
| 2014 |
Frisullo G, Calabrese M, Tortorella C, Paolicelli D, Ragonese P, Annovazzi P, Radaelli M, Malucchi S, Gallo A, Tomassini V, Nociti V, D'Onghia M, Lo Re V, Rodegher M, Solaro C, et al. Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1265-1268. PMID 24515732 DOI: 10.1177/1352458514521311 |
0.424 |
|
| 2013 |
Gajofatto A, Calabrese M, Benedetti MD, Monaco S. Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. Disease Markers. 35: 687-99. PMID 24324285 DOI: 10.1155/2013/484959 |
0.54 |
|
| 2013 |
Biundo R, Calabrese M, Weis L, Facchini S, Ricchieri G, Gallo P, Antonini A. Anatomical correlates of cognitive functions in early Parkinson's disease patients. Plos One. 8: e64222. PMID 23717572 DOI: 10.1371/Journal.Pone.0064222 |
0.305 |
|
| 2013 |
Puthenparampil M, Seppi D, Rinaldi F, Federle L, Calabrese M, Perini P, Gallo P. Increased incidence of multiple sclerosis in the Veneto region, Italy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 601-4. PMID 23599184 DOI: 10.1177/1352458512461970 |
0.532 |
|
| 2013 |
Calabrese M, Romualdi C, Poretto V, Favaretto A, Morra A, Rinaldi F, Perini P, Gallo P. The changing clinical course of multiple sclerosis: a matter of gray matter. Annals of Neurology. 74: 76-83. PMID 23494723 DOI: 10.1002/Ana.23882 |
0.494 |
|
| 2013 |
Peruzzo D, Castellaro M, Calabrese M, Veronese E, Rinaldi F, Bernardi V, Favaretto A, Gallo P, Bertoldo A. Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 457-63. PMID 23250108 DOI: 10.1038/jcbfm.2012.192 |
0.315 |
|
| 2013 |
Calabrese M, Favaretto A, Martini V, Gallo P. Grey matter lesions in MS: from histology to clinical implications. Prion. 7: 20-7. PMID 23093801 DOI: 10.4161/Pri.22580 |
0.538 |
|
| 2013 |
Calabrese M, Favaretto A, Poretto V, Romualdi C, Rinaldi F, Mattisi I, Morra A, Perini P, Gallo P. Low degree of cortical pathology is associated with benign course of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 904-11. PMID 23069877 DOI: 10.1177/1352458512463767 |
0.336 |
|
| 2013 |
Annovazzi P, Tomassini V, Bodini B, Boffa L, Calabrese M, Cocco E, Cordioli C, De Luca G, Frisullo G, Gallo A, Malucchi S, Paolicelli D, Pesci I, Radaelli M, Ragonese P, et al. A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 34: 197-203. PMID 22407022 DOI: 10.1007/S10072-012-0981-5 |
0.437 |
|
| 2012 |
Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. The Lancet. Neurology. 11: 1082-92. PMID 23153407 DOI: 10.1016/S1474-4422(12)70230-2 |
0.335 |
|
| 2012 |
Rinaldi F, Seppi D, Calabrese M, Perini P, Gallo P. Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1640-3. PMID 23100526 DOI: 10.1177/1352458512464282 |
0.522 |
|
| 2012 |
Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain : a Journal of Neurology. 135: 2952-61. PMID 23065788 DOI: 10.1093/brain/aws246 |
0.373 |
|
| 2012 |
Calabrese M, Seppi D, Cocco E, Poretto V, Rinaldi F, Perini P, Gallo P. Cortical Pathology in RRMS: Taking a Cue from Four Sisters. Multiple Sclerosis International. 2012: 760254. PMID 23056945 DOI: 10.1155/2012/760254 |
0.561 |
|
| 2012 |
Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P. Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1760-7. PMID 22570359 DOI: 10.1177/1352458512447704 |
0.57 |
|
| 2012 |
Calabrese M, Seppi D, Romualdi C, Rinaldi F, Alessio S, Perini P, Gallo P. Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population. Ajnr. American Journal of Neuroradiology. 33: 1507-11. PMID 22422186 DOI: 10.3174/Ajnr.A3011 |
0.562 |
|
| 2012 |
Calabrese M, Federle L, Bernardi V, Rinaldi F, Favaretto A, Varagnolo MC, Perini P, Plebani M, Gallo P. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 174-80. PMID 21868488 DOI: 10.1177/1352458511418550 |
0.534 |
|
| 2012 |
Calabrese M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Rinaldi F, Perini P, Gallo P. Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 418-24. PMID 21228025 DOI: 10.1177/1352458510394702 |
0.345 |
|
| 2011 |
Calabrese M, Rinaldi F, Seppi D, Favaretto A, Squarcina L, Mattisi I, Perini P, Bertoldo A, Gallo P. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. Radiology. 261: 891-8. PMID 22031708 DOI: 10.1148/radiol.11110195 |
0.387 |
|
| 2011 |
Sormani MP, Calabrese M, Signori A, Giorgio A, Gallo P, De Stefano N. Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. Plos One. 6: e26712. PMID 22028937 DOI: 10.1371/Journal.Pone.0026712 |
0.554 |
|
| 2011 |
Calabrese M, Rinaldi F, Poretto V, Gallo P. The puzzle of multiple sclerosis: gray matter finds its place. Expert Review of Neurotherapeutics. 11: 1565-8. PMID 22014135 DOI: 10.1586/Ern.11.143 |
0.578 |
|
| 2011 |
Baracchini C, Perini P, Causin F, Calabrese M, Rinaldi F, Gallo P. Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency Neurology. 77: 844-850. PMID 21849656 DOI: 10.1212/Wnl.0B013E31822C6208 |
0.505 |
|
| 2011 |
Calabrese M, Rinaldi F, Grossi P, Gallo P. Cortical pathology and cognitive impairment in multiple sclerosis Expert Review of Neurotherapeutics. 11: 425-432. PMID 21375447 DOI: 10.1586/Ern.10.155 |
0.504 |
|
| 2011 |
Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Annals of Neurology. 69: 90-9. PMID 21280079 DOI: 10.1002/ana.22228 |
0.473 |
|
| 2011 |
Rovaris M, Rocca MA, Barkhof F, Calabrese M, De Stefano N, Khalil M, Fazekas F, Fisniku L, Gallo P, Miller DH, Montalban X, Polman C, Rovira A, Sombekke MH, Sormani MP, et al. Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 319-26. PMID 21159719 DOI: 10.1177/1352458510388824 |
0.512 |
|
| 2011 |
Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P. Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 31: 317-20. PMID 20535514 DOI: 10.1007/S10072-010-0346-X |
0.452 |
|
| 2010 |
Calabrese M, Battaglini M, Giorgio A, Atzori M, Bernardi V, Mattisi I, Gallo P, De Stefano N. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology. 75: 1234-40. PMID 20739644 DOI: 10.1212/Wnl.0B013E3181F5D4Da |
0.54 |
|
| 2010 |
Calabrese M, Rinaldi F, Grossi P, Mattisi I, Bernardi V, Favaretto A, Perini P, Gallo P. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis Multiple Sclerosis. 16: 1220-1228. PMID 20670981 DOI: 10.1177/1352458510376405 |
0.33 |
|
| 2010 |
Rinaldi F, Calabrese M, Grossi P, Puthenparampil M, Perini P, Gallo P. Cortical lesions and cognitive impairment in multiple sclerosis Neurological Sciences. 31. PMID 20635113 DOI: 10.1007/S10072-010-0368-4 |
0.609 |
|
| 2010 |
Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nature Reviews. Neurology. 6: 438-44. PMID 20625376 DOI: 10.1038/nrneurol.2010.93 |
0.408 |
|
| 2010 |
Rinaldi L, Rinaldi F, Perini P, Calabrese M, Seppi D, Grossi P, Mattisi I, Barzon L, Mengoli C, Sanzari M, Palú G, Gallo P. No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1345-50. PMID 20547618 DOI: 10.1136/Jnnp.2009.201079 |
0.538 |
|
| 2010 |
Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Annals of Neurology. 67: 376-83. PMID 20373349 DOI: 10.1002/ana.21906 |
0.458 |
|
| 2010 |
Calabrese M, Mattisi I, Rinaldi F, Favaretto A, Atzori M, Bernardi V, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 401-4. PMID 19965849 DOI: 10.1136/Jnnp.2009.177733 |
0.544 |
|
| 2009 |
Rinaldi L, Perini P, Calabrese M, Gallo P. Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks Neurological Sciences. 30: 171-173. PMID 19882369 DOI: 10.1007/S10072-009-0145-4 |
0.525 |
|
| 2009 |
Rinaldi F, Perini P, Calabrese M, Rinaldi L, Gallo P. Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1359-62. PMID 19812116 DOI: 10.1177/1352458509107011 |
0.552 |
|
| 2009 |
Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Archives of Neurology. 66: 1144-50. PMID 19752305 DOI: 10.1001/archneurol.2009.174 |
0.5 |
|
| 2009 |
Rovaris M, Barkhof F, Calabrese M, De Stefano N, Fazekas F, Miller DH, Montalban X, Polman C, Rocca MA, Thompson AJ, Yousry TA, Filippi M. MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype Neurology. 72: 1693-1701. PMID 19433744 DOI: 10.1212/Wnl.0B013E3181A55Feb |
0.606 |
|
| 2009 |
Pierno AC, Turella L, Grossi P, Tubaldi F, Calabrese M, Perini P, Barachino L, Morra A, Gallo P, Castiello U. Investigation of the neural correlates underlying action observation in multiple sclerosis patients. Experimental Neurology. 217: 252-7. PMID 19285072 DOI: 10.1016/J.Expneurol.2009.02.016 |
0.348 |
|
| 2009 |
Filippi M, Calabrese M, Gallo P. Response letter regarding the article “Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study,” by Calabrese, et al.: Multiple Sclerosis Journal. 15: 404-404. DOI: 10.1177/1352458508100838 |
0.337 |
|
| 2008 |
Perini P, Calabrese M, Rinaldi L, Gallo P. Cyclophosphamide-based combination therapies for autoimmunity. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 29: S233-4. PMID 18690502 DOI: 10.1007/S10072-008-0947-9 |
0.532 |
|
| 2008 |
Calabrese M, Filippi M, Rovaris M, Mattisi I, Bernardi V, Atzori M, Favaretto A, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P. Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. Neuroimage. 42: 1324-8. PMID 18652903 DOI: 10.1016/J.Neuroimage.2008.06.028 |
0.548 |
|
| 2008 |
Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Rinaldi L, Morra A, McAuliffe MM, Perini P, Battistin L, Gallo P. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. Journal of Neurology. 255: 581-6. PMID 18227989 DOI: 10.1007/s00415-008-0752-7 |
0.382 |
|
| 2007 |
Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, Battistin L, Gallo P. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Archives of Neurology. 64: 1416-22. PMID 17923625 DOI: 10.1001/archneur.64.10.1416 |
0.452 |
|
| 2007 |
Perini P, Calabrese M, Rinaldi L, Gallo P. The safety profile of cyclophosphamide in multiple sclerosis therapy. Expert Opinion On Drug Safety. 6: 183-90. PMID 17367264 DOI: 10.1517/14740338.6.2.183 |
0.463 |
|
| 2007 |
Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJ, Barachino L, Perini P, Fischl B, Battistin L, Gallo P. Cortical atrophy is relevant in multiple sclerosis at clinical onset. Journal of Neurology. 254: 1212-20. PMID 17361339 DOI: 10.1007/s00415-006-0503-6 |
0.508 |
|
| 2006 |
Rinaldi L, Gallo P, Calabrese M, Ranzato F, Luise D, Colavito D, Motta M, Guglielmo A, Del Giudice E, Romualdi C, Ragazzi E, D'Arrigo A, Dalle Carbonare M, Leontino B, Leon A. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Brain : a Journal of Neurology. 129: 1993-2007. PMID 16870883 DOI: 10.1093/Brain/Awl179 |
0.457 |
|
| 2006 |
Perini P, Calabrese M, Tiberio M, Ranzato F, Battistin L, Gallo P. Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis: a comparative study. Journal of Neurology. 253: 1034-40. PMID 16609811 DOI: 10.1007/S00415-006-0154-7 |
0.398 |
|
| 2006 |
Perini P, Ranzato F, Calabrese M, Battistin L, Gallo P. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. 77: 953-955. PMID 16574727 DOI: 10.1136/Jnnp.2005.086116 |
0.477 |
|
| 2006 |
Laroni A, Calabrese M, Perini P, Albergoni MP, Ranzato F, Tiberio M, Battistin L, Gallo P. Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy. Journal of Neurology. 253: 636-9. PMID 16502215 DOI: 10.1007/s00415-006-0084-4 |
0.46 |
|
| Show low-probability matches. |